Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2017, Vol. 37 Issue (1): 81-88    DOI: 10.13523/j.cb.20170112
    
SNS:An Effective Strategy for Extending Ceramic Hydroxyapatite Column Life
DENG Yi-xi1, LI Ji-dong2, LI Le1, MENG Guo-ji1, YU Yu-gen1
1. Shenzhen Main Luck Pharmaceuticals Inc., Shenzhen 518029, China;
2. Bio-Rad Laboratories(Shanghai) Ltd., Shenzhen 510095, China
Download: HTML   PDF(1509KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Ceramic Hydroxyapatite (CHT) has been widely used in the manufacturing of a wide variety of monoclonal antibodies (mAbs), vaccines, and other protein therapeutics. It is an effective tool for the removal of residual host cell proteins, nucleic acids, viruses, endotoxins, and product-related contaminants such as aggregates and degradation fragments. However, damage of the CHT media and increased column back pressure are often observed at production scale-up. A transient pH excursion during elution with increased salt concentration leads to Ca2+ depletion from the CHT column. In the present study,the effect of surface neutralization system (SNS) on the life cycles of CHT media is demonstrated. Following post-loading wash, a buffer with slightly elevated pH is applied onto the column so as to prevent significant pH drop during target protein elution. The level of Ca2+ depletion in response to pH and salt concentration of the SNS buffer have been investigated, and the optimal buffer composition for maintaining the pH of column effluent near neutral been identified. This newly developed protocol has been validated for the polish purification of mAb WLB304. The dynamic binding capacity of WLB304, impurity clearance efficiency, leached Ca2+ level, pH excursion and column back pressure during purification process were closely monitored. Data indicate that the implementation of SNS can significantly reduce Ca2+ depletion and effectively extend the life time of a CHT column, without compromising its chromatography performance.



Key wordsSNS      Antibody      Calcium depletion      CHT     
Received: 25 July 2016      Published: 25 January 2017
ZTFLH:  Q819  
Cite this article:

DENG Yi-xi, LI Ji-dong, LI Le, MENG Guo-ji, YU Yu-gen. SNS:An Effective Strategy for Extending Ceramic Hydroxyapatite Column Life. China Biotechnology, 2017, 37(1): 81-88.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20170112     OR     https://manu60.magtech.com.cn/biotech/Y2017/V37/I1/81

[1] Cummings L J, Ogawa T, Tunón P. CHT ceramic hydroxyapatite:new life for an old chromatographic technique.. http://www.bio-rad.com/webroot/web/pdf/lsr/literature/Bulletin_1927B.pdf.
[2] Nakamura S, Matsumoto T, Sasaki J, et al. Effect of calcium ion concentrations on osteogenic differentiation and hematopietic stem cell niche-related protein expressions in osteoblasts. Tissue Engineering, 2010,18(8):2467-2473.
[3] Yachelini P, Falk I, Eichmann K. Deviations in thymocyte development induced by divalent and monovalent ligation of the alpha/beta T cell receptor and by its cross-linking to CD8. J Immunol, 1990,145(5):1382-1389.
[4] Grun J B, et al. Viral removal/inactivation by purification of biopharmaceuticals. Biopharm, 1992,5:22-30.
[5] Juarez-Salinas H, et al. Separation of IgG idiotypes by high-performance hydroxylapatite chromatography. Methods Enzymol, 1986,121(58):615-622.
[6] Gagnon P, Paul N G, Jie H, et al. Platform purification of IgG with CHT ceramic hydroxyapatite.. www.ibclifesciences.com.
[7] Ng P K, Snyder M A. pH-based cation exchange chromatography in the capture and elution of monoclonal antibodies. J Sep Sci, 2012,35:29-35.
[8] Bankston T, Theresa E, Dattolo L,et al. pH transients in hydroxyapatite chromatography columns-Experimental evidence and phenomenological modeling. J of Chromatography A, 2010,1217:2123-2131.
[9] Belcher R, Close R A, West T S, et al. The complexometric titration of calcium in the presence of magnesium a critical study. Talanta, 1958,1:238-244.
[10] Kim J, Vipulanandan C. Effect of pH, sulfate and sodium on the EDTA titration of calcium. Cem Concr Res, 2003,33:621-627.
[11] Pabst T, Antos D, Carta G, et al. Protein separations with induced pH gradients using cation-exchange chromatographic columns containing weak acid groups. J of Chromatogr A, 2008,1181:83-94.

[1] CHEN Xiu-yue,ZHOU Wen-feng,HE Qing,SU Bing,ZOU Ya-wen. Preparation, Purification and Identification of Bacteriophage Qβ Virus-like Particles[J]. China Biotechnology, 2021, 41(7): 42-49.
[2] CHEN Wen-jie,MIAO Xian-feng. Domestic Research and Development Status of Antibody-drug Conjugates and Strategic Layout of Key Enterprises[J]. China Biotechnology, 2021, 41(6): 105-110.
[3] XU Ye-chun,LIU Hong,LI Jian-feng,SHEN Jing-shan,JIANG Hua-liang. Recent Progress in Drug Development against COVID-19[J]. China Biotechnology, 2021, 41(6): 111-118.
[4] YUAN Bo,WANG Jie-wen,KANG Guang-bo,HUANG He. Research Progress and Application of Bispecific Nanobody[J]. China Biotechnology, 2021, 41(2/3): 78-88.
[5] MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.
[6] ZHAO Yan-shu,ZHANG Jin-hua,SONG Hao. Advances in Production of Monoclonal Antibody and Antibody Fragments in Engineered Prokaryotes and Yeast[J]. China Biotechnology, 2020, 40(8): 74-83.
[7] YANG Xiao-ying,LI Meng,ZHAO Wei,TANG Min,ZHANG Zhi-qian. Preparation and Preliminary Characterization of Anti-α2δ1/CD3 Bispecific Antibody[J]. China Biotechnology, 2020, 40(7): 9-14.
[8] WU Rui-jun,LI Zhi-fei,ZHANG Xin,PU Run,AO Yi,SUN Yan-rong. Development and Prospect of Antibody Drugs for SARS-CoV-2[J]. China Biotechnology, 2020, 40(5): 1-6.
[9] YANG Li,SHI Xiao-yu,LI Wen-lei,LI Jian,XU Han-mei. Optimization of Electroporation Conditions in Construction of Phage Display Antibody Library[J]. China Biotechnology, 2020, 40(4): 42-48.
[10] LI Tong-tong,SONG Cai-ling,YANG Kai-yue,WANG Wen-jing,CHEN Hui-yu,LIU Ming. Preparation and Neutralization Activity of Anti-Canine Parvovirus VP2 Protein Single-chain Antibody[J]. China Biotechnology, 2020, 40(4): 10-16.
[11] WANG Meng,SONG Hui-ru,CHENG Yu-jie,WANG Yi,YANG Bo,HU Zheng. Accurate Detection of Streptococcus pneumoniae by Using Ribosomal Protein L7 / L12 as Molecular Marker[J]. China Biotechnology, 2020, 40(4): 34-41.
[12] CHEN Qiu-li,YANG Li-chao,LI Hui,WEN Sha,LI Gang,HE Min. Prokaryotic Expression,Purification and Preparation of Polyclonal Antibody of Human Nek2 Protein[J]. China Biotechnology, 2020, 40(3): 31-37.
[13] LI Dong-qiao,LV Lu-cheng,YANG Yan-ping. The Research Status and Development Trend of Global Human Coronavirus Antibody Field[J]. China Biotechnology, 2020, 40(1-2): 65-70.
[14] KONG Jian-tao,ZHUANG Ying-ping,GUO Mei-jin. Enhancement of Anti-CD20 Monoclonal Antibody Expression by CHO based on DOE and Amino Acid Supplemental Strategy[J]. China Biotechnology, 2020, 40(12): 41-48.
[15] HE Meng,ZHANG Guo-lin,LI Yan,HAN Xue-bo,LIU Hong-peng,LI Xin,QIAN Ling-ling,LIU Kun-mei,GUO Le. Soluble Expression of Recombinant Antigen CagL from Helicobacter pylori Pathogenicity Island and Preparation and Analysis of Anti-CagA Polyclonal Antibody[J]. China Biotechnology, 2020, 40(11): 21-27.